NFE2L2 and myeloid sarcoma: AKBA shows a protective effect in MS rats by upregulation of the Nrf2/HO-1 signaling pathway, which was confirmed by studying neurochemical parameters in biological samples such as CSF, blood plasma, and brain homogenates.